Japanese | English

| Sitemap |

Investor Relations  |  Environmental and Social Report  |  about Eisai  |  Inquiry

Eisai Global Site Investor Relations Environmental and Social Report about Eisai Potential Suppliers Inquiry

Company Introduction Video Annual Report 2010 Environmental and Social Report 2009			News Release List July 30, 2010 Continuation of Policy for Protection of the Company's Corporate Value and Common Interests of Shareholders (Shareholder Rights Plan) July 24, 2010 EISAI ANNOUNCES U.S. FDA APPROVAL FOR NEW HIGHER DOSE ARICEPT® 23 MG TABLET FOR THE TREATMENT OF MODERATE-TO-SEVERE ALZHEIMER’S DISEASE July 20, 2010 FDA ACCEPTS BANZEL® (RUFINAMIDE) ORAL SUSPENSION NDA FOR REVIEW
			What's New List July 30, 2010 IR “First Quarter Financial Results Explanation for the Fiscal Year Ending March 31, 2011 [Material]” July 30, 2010 IR “First Quarter Financial Results for the Fiscal Year Ending March 31, 2011” July 29, 2010 IR “Annual Report 2010”
			Information Notice of shareholder voting results for the 98th ordinary general meeting of shareholders (June 21, 2010) Notice of resolutions of the 98th ordinary general meeting of shareholders (June 18, 2010) Corporate Governance Report updated (March 31, 2010)

Privacy Policy  |  Terms of Use  |  Accessibility